Skip to content

Halozyme Therapeutics, Inc.

HALO Nasdaq SEC CIK 1159036

Follow Halozyme Therapeutics Weekly email: filings, results, news

News

9 stories filed under Halozyme Therapeutics, grouped into ongoing threads

Call transcript

Thread · 3 stories

Halozyme (HALO) Q2 2026 Earnings Call Transcript

Earnings 41 d ago

Halozyme Therapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation

Earnings 48 d ago

Halozyme Therapeutics, Inc. (HALO) Q2 2026 Earnings Call Transcript

Earnings 48 d ago

More coverage

Halozyme Therapeutics stock hits all-time high at 109.69 USD

Markets 22 d ago

Tight Action In HALO Stock Sets Up Heavenly Gains

Markets 27 d ago

Halo Minerals (HALO) Secures £4 Million in AIM IPO and Advances Playa Verde Copper Project in H1 2026 Interim Report

Deals 27 d ago also on AIM

Halozyme Therapeutics: Running Through 2027

Markets 31 d ago

Incyte Corporation (INCY) has the Bigger Revenue Base, but Could Halozyme Therapeutics, Inc. (HALO) have the Better Economics?

Markets 41 d ago also on INCY

These nontech stocks can ride the AI build-out for years

Tech 42 d ago

Next results

NOV5

Q2 2026 results

Thursday · estimated from the filing cadence

Profile

Headquarters: SAN DIEGO, CA, United States
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Peers

Where this page comes from

Profile · SEC EDGAR

Next results · estimated from the filing cadence (SEC EDGAR)

News · 9 stories clustered from the RSS aggregator